Novavax Inc. sell JPMorgan Chase & Co.
Start price
18.11.25
/
50%
€5.63
Target price
18.11.26
€5.18
Performance (%)
12.75%
Price
22:25
€6.35
Summary
This prediction is currently active. The SELL prediction by JPMorgan_Chase___Co_ currently has a performance of 12.75%. This prediction currently runs until 18.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -6.105% | -6.105% |
| iShares Core DAX® | 3,90 % | 2,67 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % |
| iShares S&P 500 | -0,88 % | -1,49 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat